Skip to main content
Leadership team

Shaping the future of rare disease

We don’t just work for a company; we work for a cause. Our mission has led us to bring a spirit of innovation to every aspect of the drug development process. From discovery, to the design of our clinical trials, our deep passion for patients drives us to urgently seek ways to do things differently.

Meet our executive leadership

This inspiring group of innovators, mavericks, and big thinkers are changing the face of treatments for rare diseases — all for the good of patients and their families.​
Neil Almstead

Neil Almstead, Ph.D.

Chief Technical Operations Officer
Headshot of John Baird

John Baird, Ph.D.

Chief of Staff to the CEO
Mark Boulding

Mark E. Boulding

Executive Vice President and Chief Legal Officer
Headshot of Lee Golden

Lee Golden, M.D.

Chief Medical Officer
Pierre Gravier

Pierre Gravier

Chief Financial Officer
Mary Frances Harmon

Mary Frances Harmon

Senior Vice President, Corporate and Patient Relations
Kylie O'Keefe

Kylie O’Keefe

Chief Commercial Officer
Eric Pauwels

Eric Pauwels

Chief Business Officer
Headshot of Hege Sollie-Zetlmayer

Hege Sollie-Zetlmayer

Senior Vice President, Human Resources
Headshot of Christine Utter

Christine Utter

Senior Vice President, Chief Accounting Officer and Head of People Services
Headshot of Ellen Welch

Ellen Welch, Ph.D.

Chief Scientific Officer
Martin Rexroad
The way hearts and minds come together here to solve problems for the benefit of the patient, makes PTC a special place.”
Martin Rexroad Chief Culture & Community Officer
Careers with Purpose

Explore job opportunities at PTC

Three of PTC's scientists